This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Hospital Acquired and Community Acquired MRSA in GI Lab

This study has been withdrawn prior to enrollment.
(study lacked funding to recruit)
Information provided by:
Indiana University Identifier:
First received: December 19, 2007
Last updated: February 29, 2016
Last verified: February 2016
Hospital acquired and community acquired methicillin resistant staph aureus (MRSA) has become an important health issue for in recent years. Up to two thirds of patients that are hospitalized may be colonized with MRSA. The prevalence in the community is also on the rise and affects the young and healthy. It is unclear what the true prevalence of MRSA is in our own hospital and outpatient setting. This information would be relevant to how healthcare staff adhere to contact and universal precautions. : The purpose of this study is to determine the prevalence of MRSA in patients that have gastrointestinal endoscopy and endoscopic ultrasound.

Hospital Acquired MRSA Community Acquired MRSA

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Hospital Acquired and Community Acquired Methicillin Resistant Staph Aureus in the Outpatient Gastrointestinal Lab: A Prospective Study of Prevalence

Resource links provided by NLM:

Further study details as provided by Indiana University:

Primary Outcome Measures:
  • The objective of this prospective study is to identify the prevalence of MRSA in patients that use the Indiana University GI lab. [ Time Frame: less than one year ]

Biospecimen Retention:   Samples Without DNA
buccal swab for saliva

Enrollment: 0
Study Start Date: April 2009
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
gastrointestinal lab of oupatient and inpatients

Inclusion Criteria:

  • No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.

Subjects must provide signed written informed consent.

Exclusion Criteria:

  • Inability to provide written informed consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00577343

United States, Indiana
Clarian/Indiana University Hospital
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
  More Information

Responsible Party: Dr. Julia LeBlanc, Indiana University Identifier: NCT00577343     History of Changes
Other Study ID Numbers: 0705-31
Study First Received: December 19, 2007
Last Updated: February 29, 2016 processed this record on August 16, 2017